119 related articles for article (PubMed ID: 18281249)
1. Constitutional CHEK2 mutations are associated with a decreased risk of lung and laryngeal cancers.
Cybulski C; Masojc B; Oszutowska D; Jaworowska E; Grodzki T; Waloszczyk P; Serwatowski P; Pankowski J; Huzarski T; Byrski T; Górski B; Jakubowska A; Debniak T; Wokolorczyk D; Gronwald J; Tarnowska C; Serrano-Fernández P; Lubinski J; Narod SA
Carcinogenesis; 2008 Apr; 29(4):762-5. PubMed ID: 18281249
[TBL] [Abstract][Full Text] [Related]
2. Effect of CHEK2 missense variant I157T on the risk of breast cancer in carriers of other CHEK2 or BRCA1 mutations.
Cybulski C; Górski B; Huzarski T; Byrski T; Gronwald J; Debniak T; Wokolorczyk D; Jakubowska A; Serrano-Fernández P; Dork T; Narod SA; Lubinski J
J Med Genet; 2009 Feb; 46(2):132-5. PubMed ID: 18930998
[TBL] [Abstract][Full Text] [Related]
3. Germline CHEK2 mutations and colorectal cancer risk: different effects of a missense and truncating mutations?
Cybulski C; Wokołorczyk D; Kładny J; Kurzawski G; Suchy J; Grabowska E; Gronwald J; Huzarski T; Byrski T; Górski B; D Ecedil Bniak T; Narod SA; Lubiński J
Eur J Hum Genet; 2007 Feb; 15(2):237-41. PubMed ID: 17106448
[TBL] [Abstract][Full Text] [Related]
4. CHEK2-positive breast cancers in young Polish women.
Cybulski C; Górski B; Huzarski T; Byrski T; Gronwald J; Debniak T; Wokolorczyk D; Jakubowska A; Kowalska E; Oszurek O; Narod SA; Lubinski J
Clin Cancer Res; 2006 Aug; 12(16):4832-5. PubMed ID: 16914568
[TBL] [Abstract][Full Text] [Related]
5. Uncommon CHEK2 mis-sense variant and reduced risk of tobacco-related cancers: case control study.
Brennan P; McKay J; Moore L; Zaridze D; Mukeria A; Szeszenia-Dabrowska N; Lissowska J; Rudnai P; Fabianova E; Mates D; Bencko V; Foretova L; Janout V; Chow WH; Rothman N; Chabrier A; Gaborieau V; Odefrey F; Southey M; Hashibe M; Hall J; Boffetta P; Peto J; Peto R; Hung RJ
Hum Mol Genet; 2007 Aug; 16(15):1794-801. PubMed ID: 17517688
[TBL] [Abstract][Full Text] [Related]
6. Breast cancer predisposing alleles in Poland.
Górski B; Cybulski C; Huzarski T; Byrski T; Gronwald J; Jakubowska A; Stawicka M; Gozdecka-Grodecka S; Szwiec M; Urbański K; Mituś J; Marczyk E; Dziuba J; Wandzel P; Surdyka D; Haus O; Janiszewska H; Debniak T; Tołoczko-Grabarek A; Medrek K; Masojć B; Mierzejewski M; Kowalska E; Narod SA; Lubiński J
Breast Cancer Res Treat; 2005 Jul; 92(1):19-24. PubMed ID: 15980987
[TBL] [Abstract][Full Text] [Related]
7. A deletion in CHEK2 of 5,395 bp predisposes to breast cancer in Poland.
Cybulski C; Wokołorczyk D; Huzarski T; Byrski T; Gronwald J; Górski B; Debniak T; Masojć B; Jakubowska A; van de Wetering T; Narod SA; Lubiński J
Breast Cancer Res Treat; 2007 Mar; 102(1):119-22. PubMed ID: 16897426
[TBL] [Abstract][Full Text] [Related]
8. The CHEK2 gene I157T mutation and other alterations in its proximity increase the risk of sporadic colorectal cancer in the Czech population.
Kleibl Z; Havranek O; Hlavata I; Novotny J; Sevcik J; Pohlreich P; Soucek P
Eur J Cancer; 2009 Mar; 45(4):618-24. PubMed ID: 18996005
[TBL] [Abstract][Full Text] [Related]
9. A variant in the CHEK2 promoter at a methylation site relieves transcriptional repression and confers reduced risk of lung cancer.
Zhang S; Lu J; Zhao X; Wu W; Wang H; Lu J; Wu Q; Chen X; Fan W; Chen H; Wang F; Hu Z; Jin L; Wei Q; Shen H; Huang W; Lu D
Carcinogenesis; 2010 Jul; 31(7):1251-8. PubMed ID: 20462940
[TBL] [Abstract][Full Text] [Related]
10. Pathology of breast cancer in women with constitutional CHEK2 mutations.
Huzarski T; Cybulski C; Domagała W; Gronwald J; Byrski T; Szwiec M; Woyke S; Narod SA; Lubiński J
Breast Cancer Res Treat; 2005 Mar; 90(2):187-9. PubMed ID: 15803365
[TBL] [Abstract][Full Text] [Related]
11. Estrogen receptor status in CHEK2-positive breast cancers: implications for chemoprevention.
Cybulski C; Huzarski T; Byrski T; Gronwald J; Debniak T; Jakubowska A; Górski B; Wokołorczyk D; Masojć B; Narod SA; Lubiński J
Clin Genet; 2009 Jan; 75(1):72-8. PubMed ID: 19021634
[TBL] [Abstract][Full Text] [Related]
12. Germline CHEK2 mutations in Jewish Ashkenazi women at high risk for breast cancer.
Laitman Y; Kaufman B; Lahad EL; Papa MZ; Friedman E
Isr Med Assoc J; 2007 Nov; 9(11):791-6. PubMed ID: 18085035
[TBL] [Abstract][Full Text] [Related]
13. Different CHEK2 germline mutations are associated with distinct immunophenotypic molecular subtypes of breast cancer.
Domagala P; Wokolorczyk D; Cybulski C; Huzarski T; Lubinski J; Domagala W
Breast Cancer Res Treat; 2012 Apr; 132(3):937-45. PubMed ID: 21701879
[TBL] [Abstract][Full Text] [Related]
14. Synergistic interaction of variants in CHEK2 and BRCA2 on breast cancer risk.
Serrano-Fernández P; Debniak T; Górski B; Bogdanova N; Dörk T; Cybulski C; Huzarski T; Byrski T; Gronwald J; Wokołorczyk D; Narod SA; Lubiński J
Breast Cancer Res Treat; 2009 Sep; 117(1):161-5. PubMed ID: 19030985
[TBL] [Abstract][Full Text] [Related]
15. The association of sequence variants in DNA repair and cell cycle genes with cancers of the upper aerodigestive tract.
Hall J; Hashibe M; Boffetta P; Gaborieau V; Moullan N; Chabrier A; Zaridze D; Shangina O; Szeszenia-Dabrowska N; Mates D; Janout V; Fabiánová E; Holcatova I; Hung RJ; McKay J; Canzian F; Brennan P
Carcinogenesis; 2007 Mar; 28(3):665-71. PubMed ID: 17040931
[TBL] [Abstract][Full Text] [Related]
16. The contribution of founder mutations to early-onset breast cancer in French-Canadian women.
Ghadirian P; Robidoux A; Zhang P; Royer R; Akbari M; Zhang S; Fafard E; Costa M; Martin G; Potvin C; Patocskai E; Larouche N; Younan R; Nassif E; Giroux S; Narod SA; Rousseau F; Foulkes WD
Clin Genet; 2009 Nov; 76(5):421-6. PubMed ID: 19863560
[TBL] [Abstract][Full Text] [Related]
17. p53 mutations and exposure to environmental tobacco smoke in a multicenter study on lung cancer.
Husgafvel-Pursiainen K; Boffetta P; Kannio A; Nyberg F; Pershagen G; Mukeria A; Constantinescu V; Fortes C; Benhamou S
Cancer Res; 2000 Jun; 60(11):2906-11. PubMed ID: 10850436
[TBL] [Abstract][Full Text] [Related]
18. Deleterious CHEK2 1100delC and L303X mutants identified among 38 human breast cancer cell lines.
Wasielewski M; Hanifi-Moghaddam P; Hollestelle A; Merajver SD; van den Ouweland A; Klijn JG; Ethier SP; Schutte M
Breast Cancer Res Treat; 2009 Jan; 113(2):285-91. PubMed ID: 18297428
[TBL] [Abstract][Full Text] [Related]
19. Polymorphism in cytochrome P450 CYP2D6, CYP1A1, CYP2E1 and glutathione S-transferase, GSTM1, GSTM3, GSTT1 and susceptibility to tobacco-related cancers: studies in upper aerodigestive tract cancers.
Matthias C; Bockmühl U; Jahnke V; Jones PW; Hayes JD; Alldersea J; Gilford J; Bailey L; Bath J; Worrall SF; Hand P; Fryer AA; Strange RC
Pharmacogenetics; 1998 Apr; 8(2):91-100. PubMed ID: 10022746
[TBL] [Abstract][Full Text] [Related]
20. CHEK2 variants predispose to benign, borderline and low-grade invasive ovarian tumors.
Szymanska-Pasternak J; Szymanska A; Medrek K; Imyanitov EN; Cybulski C; Gorski B; Magnowski P; Dziuba I; Gugala K; Debniak B; Gozdz S; Sokolenko AP; Krylova NY; Lobeiko OS; Narod SA; Lubinski J
Gynecol Oncol; 2006 Sep; 102(3):429-31. PubMed ID: 16828850
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
